Cancer and Metabolism | February 9-10 | Austin TX, USA and online

Now in its 7th year, this two-day, hybrid conference will bring together researchers to explore the complex interactions between metabolic reprogramming and cancer biology. This event aims to foster collaboration and inspire new approaches  in cancer research and treatment. Tickets are available from $325 (virtual) and $375 (in-person) – book before October 7 to lock in these early bird prices!

Scientific Organizers:

• Eyal Gottlieb – MD Anderson, USA
• Karen Vousden – The Francis Crick Institute, UK
• Ralph DeBerardinis – UT Southwestern Medical Center, USA
• Oliver Maddocks – Faeth Therapeutics, UK
• Abcam

The conference will cover on four critical topics, each featuring three key opinion leaders:

• Host-tumor interaction
  • Peter Mullen – Keck School of Medicine of USC, USA
  • Eileen White – Rutgers Cancer Institute, USA
  • Ayelet Erez – Weizmann Institute of Science, Israel
• Immunometabolism and tumor microenvironment
  • Erika Pearce – Johns Hopkins School of Medicine, USA
  • Karuna Ganesh – Memorial Sloan Kettering Cancer Center, USA
  • Alec Kimmelman – NYU Langone Health, USA
• Tumor initiation therapy and progression
  • Ana Gomes – Moffitt Cancer Center, USA
  • Kivanç Birsoy – Rockefeller University, USA
  • Dan Wahl – University of Michigan Medical School, USA
• Diet and nutrient transporters
  • Lydia Lynch – Harvard University, USA
  • Matt Vander Heiden – Koch Institute for Cancer Research at MIT, USA
  • Ömer Yilmaz – Koch Institute for Cancer Research at MIT, USA

Looking for opportunities to share your research with the wider community?
Consider submitting an abstract to present at this conference.

• Short talk deadline: October 7
• Poster deadline: December 9

(No Ratings Yet)

Loading...